Sanofi Gaucher pill application gets priority FDA review

PARIS (Reuters) - French drugmaker Sanofi said U.S. authorities had decided to carry out a priority review of its experimental pill for patients with Gaucher disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news